A MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED, PARALLEL-GROUP PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EPITHELIUM-ON CORNEAL CROSS-LINKING IN SUBJECTS 8 TO 45 YEARS OF AGE WITH KERATOCONUS (APRICITY-B)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/eyes.jpg)
Description
To evaluate the efficacy of the riboflavin-sodium iodide solution followed by ultraviolet A (UVA) exposure and epithelium-on corneal crosslinking (CXL) assessed by visual acuity measurement in subjects with keratoconus.
Details
Age
Child to Adult
Eligibility
Males and females ≥ 8 to ≤ 45 years of age with the clinical diagnosis of keratoconus. Diagnosis will be confirmed by tomographic imaging
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Michael Taravella](https://som.ucdenver.edu/FIMS/Content/faculty/15345/CU-Doctors-15345.jpg)
Michael Taravella
Study ID
Protocol Number: 23-1425
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers